E-LIB Suche - Ergebnisse für: Prat, J.

1

49P A ctDNA tool for identifying ESR1-mutated biology in ES..:

Fructuoso, I. Garcia ; Martínez-Sáez, O. ; Pardo, F....
ESMO Open. 9 (2024) - p. 103056 , 2024

Link: https://doi.org/10.1016/..

2

163P Characterization of HER2-low breast cancer in young wo..:

Schettini, F. ; Blondeaux, E. ; Molinelli, C....
ESMO Open. 9 (2024) - p. 103185 , 2024

Link: https://doi.org/10.1016/..

3

199P Adoptive PD1+ tumor-infiltrating lymphocyte therapy fo..:

Angelats, L. ; Eslava, M. Santisteban ; Manich, C. Saura...
ESMO Open. 9 (2024) - p. 103221 , 2024

Link: https://doi.org/10.1016/..

4

94P Biological effects of a pre-operative radiotherapy boos..:

Gomà, C. ; Brasó-Maristany, F. ; Oses, G....
ESMO Open. 9 (2024) - p. 103165 , 2024

Link: https://doi.org/10.1016/..

5

10P PIK3CA mutation and response to neoadjuvant taselisib a..:

Fimereli, D. ; Nuciforo, P.G. ; de Azambuja, E....
ESMO Open. 9 (2024) - p. 103019 , 2024

Link: https://doi.org/10.1016/..

6

213P Sequencing antibody-drug conjugates (ADCs) in patients..:

Morganti, S. ; Tarantino, P. ; Graham, N....
ESMO Open. 9 (2024) - p. 103235 , 2024

Link: https://doi.org/10.1016/..

7

182MO Trastuzumab deruxtecan (T-DXd) vs treatment of physic..:

Kim, S-B. ; André, F. ; Takano, T....
ESMO Open. 9 (2024) - p. 103204 , 2024

Link: https://doi.org/10.1016/..

8

Dark Energy Survey Year 3 results: Simulation-based cosmolo..:

Gatti, M. ; Jeffrey, N. ; Whiteway, L....
Physical Review D. 109 (2024) 6 - p. , 2024

Link: https://doi.org/10.1103/..

9

11P Influence of ctDNA variant allele frequency (VAF) on su..:

Fructuoso, I. Garcia ; Martínez-Sáez, O. ; Conte, B....
ESMO Open. 9 (2024) - p. 103020 , 2024

Link: https://doi.org/10.1016/..

10

8P Evaluating HER2DX pCR-Score and MRI response in predicti..:

Pascual, T. ; Martínez-Sáez, O. ; Brunet, L. Pare...
ESMO Open. 9 (2024) - p. 103017 , 2024

Link: https://doi.org/10.1016/..

11

Unraveling the clinicopathological and molecular changes in..:

Schettini, F. ; Nucera, S. ; Brasó-Maristany, F....
ESMO Open. 9 (2024) 7 - p. 103619 , 2024

Link: https://doi.org/10.1016/..

12

14P Assessing the predictive value of HER2DX pCR-score for ..:

Martínez-Sáez, O. ; Marin, M. ; Brunet, L. Pare...
ESMO Open. 9 (2024) - p. 103023 , 2024

Link: https://doi.org/10.1016/..

13

16P Determinants of response to short preoperative endocrin..:

Bravo, R. Gómez ; Walbaum, B. ; Schettini, F....
ESMO Open. 9 (2024) - p. 103024 , 2024

Link: https://doi.org/10.1016/..

14

487P HER2DX ERBB2 mRNA assay following trastuzumab-based ch..:

Sauri Nadal, T. ; Pesantez Coronel, D.S. ; Braso Maristany, F....
Annals of Oncology. 35 (2024) - p. S194 , 2024

Link: https://doi.org/10.1016/..

15

124P Neoadjuvant durvalumab plus endocrine therapy followin..:

Verret, B. ; Lacroix-Triki, M. ; Ladoire, S....
ESMO Open. 9 (2024) - p. 103112 , 2024

Link: https://doi.org/10.1016/..